26/03/2026
We are pleased to announce the release of Vitrolife Group’s Annual Report for 2025.
Despite a volatile market, we delivered a resilient performance, continued to gain market share in key regions, and maintained our strategic focus on growth, innovation, and operational excellence. Our underlying business remains robust and well-balanced, supported by recurring customers, strong satisfaction scores, and our commitment to education and training that empowers our clients to deliver the best possible patient outcomes.
Looking ahead, we remain confident in our ability to drive sustainable, profitable growth and deliver on our mission: striving for better treatment outcomes for patients and helping more families fulfil the dream of a healthy baby.
Thanks to all our dedicated colleagues, valued customers, and committed shareholders for your trust and partnership.
Read the full report here: https://ow.ly/r0GT50Yz0pq